These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 6261496)
1. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia. Swenson PD; Escobar MR; Silverman JF Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya. Mwangi J; Gatei DG East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308 [TBL] [Abstract][Full Text] [Related]
3. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis. Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478 [TBL] [Abstract][Full Text] [Related]
4. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver. Hirohashi S; Shimosato Y; Ino Y; Kishi K J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080 [TBL] [Abstract][Full Text] [Related]
5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus e antigen and primary hepatocellular carcinoma. Lin TM; Chen CJ; Lu SN; Chang AS; Chang YC; Hsu ST; Liu JY; Liaw YF; Chang WY Anticancer Res; 1991; 11(6):2063-5. PubMed ID: 1663719 [TBL] [Abstract][Full Text] [Related]
7. [Expression of GST-pi and HBV infection in hepatocellular carcinoma]. Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Wang WL; London WT; Feitelson MA Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208 [TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)]. Volc-Platzer B; Hanak H; Weiss W; Denk H Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995 [TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases]. Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Vaiphei K; Pal NS; Arora SK Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis. Espinoza CG; Pillarisetti SG; Azar HA Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034 [TBL] [Abstract][Full Text] [Related]
13. [Identification of hepatitis B antigens in hepatic tissue in various forms of acute hepatitis]. Sarno EN; Vieira LM; Alvariz FG Arq Gastroenterol; 1984; 21(2):68-74. PubMed ID: 6393924 [TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study on X antigen of HBV (HBxAg) in primary hepatic carcinoma]. Wang WL Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):331-3. PubMed ID: 1337887 [TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study on HBsAg, HBcAg and AFP in 104 patients with small liver cancer]. Zhang SP Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):353-6. PubMed ID: 2470564 [TBL] [Abstract][Full Text] [Related]
16. [Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)]. Pedreira JD; Vargas V; Vilaseca J; Esteban R; Hernández-Sánchez JM; Guardia J; Bacardi R Med Clin (Barc); 1980 Jun; 75(2):58-60. PubMed ID: 6249978 [TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of Pre-S1 and Pre-S2 in human primary hepatic carcinoma (PHC)]. Wang WL Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):83-6. PubMed ID: 1319893 [TBL] [Abstract][Full Text] [Related]
18. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078 [TBL] [Abstract][Full Text] [Related]
19. Orcein staining of hepatitis B surface antigen in paraffin sections of liver on autopsy cases. Sakurai M; Miyaji T Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):334-9. PubMed ID: 73335 [TBL] [Abstract][Full Text] [Related]
20. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study. Ramakrishna B; Mukhopadhya A; Kurian G J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]